A V Artemeva (A V Artemyeva)

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 6

Top Topics

Positron Emission Tomography

Top Venues

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

This page only lists publications with an associated author ORCID identifier.

Publications

A N Boyko, Valentina M Alifirova, I G Lukashevich, Zoya A Goncharova, I V Greshnova, L G Zaslavsky, S V Kotov, N A Malkova, G N Mishin, Ye V Parshina, I Ye Poverennova, L N Prakhova, Stella Sivertseva, I V Smagina, N A Totolyan, Yu V Trinitatsky, T N Trushnikova, F A Khabirov, Zh Yu Chefranova, S G Shchur, V A Dudin, D V Pokhabov, A V Artemeva, Anna V Eremeeva, Yulia N Linkova, Arina V Zinkina-Orikhan
[Long-term efficacy and safety of divozilimab during 2-year treatment of multiple sclerosis patients in randomized double-blind placebo-controlled clinical trial BCD-132-4/MIRANTIBUS]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 124 (4) (2024)
A N Boyko, Valentina M Alifirova, I G Lukashevich, Zoya A Goncharova, I V Greshnova, L G Zaslavsky, S V Kotov, N A Malkova, G N Mishin, Ye V Parshina, I Ye Poverennova, L N Prakhova, Stella Sivertseva, I V Smagina, N A Totolyan, Yu V Trinitatsky, T N Trushnikova, F A Khabirov, Zh Yu Chefranova, S G Shchur, V A Dudin, D V Pokhabov, A V Artemeva, Anna V Eremeeva, Yulia N Linkova, Arina V Zinkina-Orikhan
[Long-term efficacy and safety of divozilimab during 2-year treatment of multiple sclerosis patients in randomized double-blind placebo-controlled clinical trial BCD-132-4/MIRANTIBUS]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 124 (4) (2024)
A N Boyko, Valentina M Alifirova, I G Lukashevich, Zoya A Goncharova, I V Greshnova, L G Zaslavsky, S V Kotov, N A Malkova, G N Mishin, Ye V Parshina, I Ye Poverennova, L N Prakhova, Stella Sivertseva, I V Smagina, N A Totolyan, Yu V Trinitatsky, T N Trushnikova, F A Khabirov, S G Shchur, A V Artemeva, D D Bolsun, Arina V Zinkina-Orikhan, Yulia N Linkova
[Efficacy and safety of divozilimab during 24-week treatment of multiple sclerosis patients in randomized double-blind placebo-controlled clinical trial BCD-132-2]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 123 (4) (2023)
A N Boyko, Valentina M Alifirova, I G Lukashevich, Zoya A Goncharova, I V Greshnova, L G Zaslavsky, S V Kotov, N A Malkova, G N Mishin, Ye V Parshina, I Ye Poverennova, L N Prakhova, Stella Sivertseva, I V Smagina, N A Totolyan, Yu V Trinitatsky, T N Trushnikova, F A Khabirov, S G Shchur, A V Artemeva, D D Bolsun, Arina V Zinkina-Orikhan, Yulia N Linkova
[Efficacy and safety of divozilimab during 24-week treatment of multiple sclerosis patients in randomized double-blind placebo-controlled clinical trial BCD-132-2]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 123 (4) (2023)
A N Boyko, Valentina M Alifirova, I G Lukashevich, Zoya A Goncharova, I V Greshnova, L G Zaslavsky, S V Kotov, N A Malkova, G N Mishin, Ye V Parshina, I Ye Poverennova, L N Prakhova, Stella Sivertseva, I V Smagina, N A Totolyan, Yu V Trinitatsky, T N Trushnikova, F A Khabirov, S G Shchur, A V Artemeva, D D Bolsun, Arina V Zinkina-Orikhan, Yulia N Linkova
[Efficacy and safety of divozilimab during 24-week treatment of multiple sclerosis patients in randomized double-blind placebo-controlled clinical trial BCD-132-2]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 123 (4) (2023)
A N Boyko, Valentina M Alifirova, I G Lukashevich, Zoya A Goncharova, I V Greshnova, L G Zaslavsky, S V Kotov, N A Malkova, G N Mishin, Ye V Parshina, I Ye Poverennova, L N Prakhova, Stella Sivertseva, I V Smagina, N A Totolyan, Yu V Trinitatsky, T N Trushnikova, F A Khabirov, S G Shchur, A V Artemeva, D D Bolsun, Arina V Zinkina-Orikhan, Yulia N Linkova
[Efficacy and safety of divozilimab during 24-week treatment of multiple sclerosis patients in randomized double-blind placebo-controlled clinical trial BCD-132-2]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 123 (4) (2023)